Lupivor 5mg Tablet contains Vortioxetine 5mg, an antidepressant indicated for the treatment of major depressive disorder (MDD) in adults. Vortioxetine is a multimodal serotonergic agent that functions primarily as a serotonin reuptake inhibitor and modulates various serotonin receptors, contributing to its antidepressant and anxiolytic effects. The pharmacological profile of Vortioxetine enhances serotonergic activity by inhibiting the serotonin transporter and acting as an agonist or antagonist at specific serotonin receptor subtypes, thereby improving mood, cognitive function, and overall quality of life in patients with depression. Lupivor is typically administered orally once daily, with or without food, and dosage adjustments may be necessary based on clinical response and tolerability. Common adverse effects include nausea, headache, dizziness, and gastrointestinal disturbances, which are generally mild to moderate and tend to diminish over time. Caution is advised when prescribing Lupivor to patients with a history of seizures, bipolar disorder, or those taking concomitant serotonergic agents due to the risk of serotonin syndrome. Regular monitoring and clinical evaluation are recommended to assess therapeutic efficacy and safety. Lupivor 5mg Tablet should be used under medical supervision, with adherence to prescribed dosage and duration to optimize treatment outcomes.